UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Reliability of methods for hepatitis B virus DNA detection

Journal of Clinical Microbiology, 1995-01, Vol.33 (1), p.225-228

1995

Volltextzugriff (PDF)

Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable

Vaccine, 2002-07, Vol.20 (23), p.2899-2905

2002

Volltextzugriff (PDF)

Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture

Antimicrobial Agents and Chemotherapy, 1994-09, Vol.38 (9), p.2180-2182

1994

Volltextzugriff (PDF)

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

Journal of viral hepatitis, 2006-02, Vol.13 (2), p.96-103

2006

Volltextzugriff (PDF)

Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen

Journal of general virology, 1999-08, Vol.80 (8), p.2121-2126

1999

Volltextzugriff (PDF)

Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients

Journal of hepatology, 2000-06, Vol.32 (6), p.1040-1041

2000

Volltextzugriff (PDF)

Hepatitis B surface antigen (HBsAg) derived from yeast cells ( Hansenula polymorpha) used to establish an influence of antigenic subtype (adw 2, adr, ayw 3) in measuring the immune response after vaccination

Vaccine, 2002-05, Vol.20 (17), p.2191-2196

2002

Volltextzugriff (PDF)

Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?

Journal of viral hepatitis, 2002-05, Vol.9 (3), p.221-228

2002

Volltextzugriff (PDF)

Hepatitis B reactivation after lamivudine

The Lancet (British edition), 1995-10, Vol.346 (8983), p.1156-1157

1995

Volltextzugriff (PDF)

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infection

Antiviral research, 1993-06, Vol.21 (2), p.141-153

1993

Volltextzugriff (PDF)

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg

Vaccine, 2001-06, Vol.19 (27), p.3671-3680

2001

Volltextzugriff (PDF)

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

Journal of medical virology, 2002-03, Vol.66 (3), p.304-311

2002

Volltextzugriff (PDF)

Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes

Journal of medical virology, 2001-08, Vol.64 (4), p.427-434

2001

Volltextzugriff (PDF)

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

Journal of hepatology, 1994, Vol.20 (4), p.483-486

1994

Volltextzugriff (PDF)

Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine

Journal of psychosomatic research, 1993-05, Vol.37 (4), p.361-369

1993

Volltextzugriff (PDF)

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

Vaccine, 2000-02, Vol.18 (15), p.1531-1538

2000

Volltextzugriff (PDF)

Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon

Antimicrobial Agents and Chemotherapy, 1993-03, Vol.37 (3), p.595-597

1993

Volltextzugriff (PDF)

Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers

Vaccine, 1994-05, Vol.12 (6), p.532-534

1994

Volltextzugriff (PDF)

Characteristics of the early phase of chronicity in acute hepatitis B infection

Journal of medical virology, 1999-04, Vol.57 (4), p.331-336

1999

Volltextzugriff (PDF)

Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication

Journal of medical virology, 2001-03, Vol.63 (3), p.217-219

2001

Volltextzugriff (PDF)

Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands

Journal of Clinical Microbiology, 1994-02, Vol.32 (2), p.306-310

1994

Volltextzugriff (PDF)

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients

Journal of hepatology, 1998-06, Vol.28 (6), p.951-959

1998

Volltextzugriff (PDF)

New nucleoside analogues for chronic hepatitis B

Journal of hepatology, 1995, Vol.22 (1 Suppl), p.52-56

1995

Volltextzugriff (PDF)

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

Hepatology (Baltimore, Md.), 1999-07, Vol.30 (1), p.238-243

1999

Volltextzugriff (PDF)

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment

Journal of hepatology, 1995-03, Vol.22 (3), p.263-267

1995

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(145)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(111)
Life Sciences & Biomedicine
(76)
Science & Technology
(76)
Biological And Medical Sciences
(68)
Medical Sciences
(52)
Female
(50)
Adult
(42)
Male
(41)
Virology
(35)
Hepatitis B Virus
(34)
Hepatitis B - Immunology
(30)
Infectious Diseases
(29)
Middle Aged
(28)
Hepatitis B - Prevention & Control
(26)
Viral Diseases
(24)
Gastroenterology & Hepatology
(23)
Human Viral Diseases
(23)
Hepatitis B Surface Antigens - Immunology
(22)
Microbiology
(21)
Viral Hepatitis
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reliability of methods for hepatitis B virus DNA detection

Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable

Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen

Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients

Hepatitis B surface antigen (HBsAg) derived from yeast cells ( Hansenula polymorpha) used to establish an influence of antigenic subtype (adw 2, adr, ayw 3) in measuring the immune response after vaccination

Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?

Hepatitis B reactivation after lamivudine

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infection

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon

Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers

Characteristics of the early phase of chronicity in acute hepatitis B infection

Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication

Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients

New nucleoside analogues for chronic hepatitis B

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment

Suchergebnisse filtern